Ecstasy’s path to approval for PTSD treatment faces doubts from FDA staff
Washington Post
A preliminary review by FDA raised questions about the data supporting MDMA-assisted therapy, which is aiming to become the first psychedelic treatment to win agency approval.
https://www.washingtonpost.com/business/2024/05/31/fda-mdma-ecstasy-therapy/